Anti-Inflammatory Effect of miR-197-3p-Loaded Microvesicles in Familial Mediterranean Fever Mouse Model
Yeliz Z Akkaya-Ulum1, Emre Nalbant1, Baris Ulum2
1Department of Medical Biology, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.
Cell Biochemistry and Function
|April 3, 2026
Summary
Microvesicles loaded with miR-197-3p show promise in treating Familial Mediterranean Fever (FMF) by reducing inflammation and improving disease features in a mouse model.
Area of Science:
- Immunology
- Genetics
- Nanomedicine
Background:
- Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disease caused by MEFV gene mutations.
- These mutations lead to excessive inflammation via pyrin inflammasome activation and cytokine release.
- The V726A knock-in (KI) mouse model accurately reflects FMF's clinical and immunological aspects.
Purpose of the Study:
- To evaluate miR-197-3p-loaded microvesicles (MVs) as a potential cell-free therapy for FMF.
- To assess the therapeutic efficacy in the FMF KI mouse model.
Main Methods:
- Microvesicles (MVs) were purified and characterized using Cryo-Transmission Electron Microscopy (Cryo-TEM).
- miR-197-3p-loaded MVs were administered to FMF KI mice via retro-orbital injection.
- Outcomes measured included IL-1β levels, CD11b expression, spleen weight, and morphological features.
Main Results:
- Treatment with miR-197-3p-loaded MVs significantly reduced IL-1β secretion and CD11b expression in FMF KI mice.
- Clinical manifestations of inflammation were improved following MV treatment.
- The MVs demonstrated appropriate size and integrity for nucleic acid delivery.
Conclusions:
- miR-197-3p-loaded MVs represent a promising, cell-free therapeutic strategy for modulating inflammation in FMF.
- This approach shows potential for treating autoinflammatory diseases.
- Further research is needed for clinical translation.
